Zorvolex
Product Images NDC 42211-203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zorvolex (NDC 42211-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Iroko Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zorvolex 01)

Chemical Structure (Zorvolex 01)
Chemical structure of the active ingredient in Zorvolex by Iroko Pharmaceuticals LLC, showing a compound with two chlorines attached to a benzene ring, linked to an amine group connected to another benzene ring and a carboxylic acid group.*
FDA Label Image

Figure 1 (Zorvolex 02)

Figure 1 (Zorvolex 02)
A line graph comparing mean VAS pain intensity scores over 48 hours for Zorvolex Capsules at 35 mg TID, 18 mg TID, and placebo. The y-axis represents pain scores from 0 to 100, and the x-axis represents time in hours from 0 to 48. Both Zorvolex doses show decreasing pain scores over time, lower than the placebo group.*
FDA Label Image

Figure 2 (Zorvolex 03)

Figure 2 (Zorvolex 03)
A Kaplan-Meier plot showing the proportion of patients achieving various percentages of reduction from baseline in WOMAC pain subscale scores. The graph compares patients taking Zorvolex Capsules 35 mg TID to those receiving placebo, with the Zorvolex group represented by a solid line and the placebo group by a dashed line. The x-axis indicates percentage reduction from baseline, and the y-axis shows the proportion of patients achieving that reduction.*
FDA Label Image

Principal Display Panel (18 mg Capsule Bottle Label)

Principal Display Panel (18 mg Capsule Bottle Label)
Zorvolex (diclofenac) capsules 18 mg label, showing a blue and gray capsule image marked with '18 mg' and 'IP-203'. The label indicates 90 capsules and prescription only. Distributed by Iroko Pharmaceuticals LLC, Philadelphia, PA. Includes a barcode and medication guide instructions.*
FDA Label Image

Principal Display Panel (35 mg Capsule Bottle Label)

Principal Display Panel (35 mg Capsule Bottle Label)
Label for Zorvolex (diclofenac) capsules, 35 mg strength. The label shows a capsule image half green and half blue with '35 mg' and 'IP-204' on it. It states 'Rx Only' and '90 Capsules' with distribution by Iroko Pharmaceuticals LLC. A barcode is present on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.